 |
|
Impact of subsequent chemotherapy on the survival of elderly patients with extensive stage small cell lung cancer
Eun Joo Kang, Yoon Ji Choi, Se Ryeon Lee, Hwa Jung Sung, Jung Sun Kim
Korean J Intern Med. 2020;35(6):1468-1476. Published online 2020 Apr 29 DOI: https://doi.org/10.3904/kjim.2019.136
|
|
Citations to this article as recorded by
 Inhibiting nonhomologous end-joining repair would promote the antitumor activity of gemcitabine in nonsmall cell lung cancer cell lines
Nannan Guo, Shaojun Li, Bo Liu, Ping Chen, Jingbo Li, Yunlong Zhao, Yingnan Zhao, Jian Tang, Wen Zhang
Anti-Cancer Drugs.2022; 33(5): 502. CrossRef Advanced age is not the decisive factor in chemotherapy of small cell lung cancer: a population-based study
Hanyu Rao, Shunping Zhou, Aihong Mei, Anjie Yao, Shuanshuan Xie
Aging.2022; 14(11): 4827. CrossRef Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study
Lauren Averett Byers, Dmitry Bentsion, Steven Gans, Konstantin Penkov, ChoonHee Son, Anne Sibille, Taofeek K. Owonikoko, Harry J.M. Groen, Carl M. Gay, Junya Fujimoto, Patricia de Groot, Martin Dunbar, Kingston Kang, Lei He, Vasudha Sehgal, Jaimee Glasgow
Clinical Cancer Research.2021; 27(14): 3884. CrossRef
|